INSR and Parkinson disease: DA-HGL identifies disease-specific functional terms (e.g. “insulin receptor binding” (GO:0005158) in diabetes and “cellular response to oxidative stress” (GO:0034599) in Parkinson’s disease), revealing core pathological mechanisms and therapeutic targets.